Synthesis and in Vitro Biological Evaluation of Hybrids from Tetrahydro-β-carboline and Hydroxylcinnamic Acid as Antitumor Carcinoma Agents

被引:16
作者
Lin, Ying [1 ]
Xia, Xuanping [2 ]
Yao, Rongxin [1 ]
Ni, Li [3 ]
Hu, Jie [4 ]
Guo, Wenjian [1 ]
Zhu, Baoling [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Hematol & Oncol, Wenzhou 325035, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Wenzhou 325035, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Lab, Wenzhou 325035, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Dept Pharm, Wenzhou 325035, Zhejiang, Peoples R China
关键词
synthesis; tetrahydro-beta-carboline; hydroxylcinnamic acid; anti-tumor agent; inhibitory activity; cell apoptosis; FERULIC ACID; DESIGN; ANALOGS; DERIVATIVES; ALKALOIDS; CELLS;
D O I
10.1248/cpb.c13-00902
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel hybrids 8a-j and 9a-j were designed and synthesized by coupling the carboxyl group of hydroxylcinnamic acids with tetrahydro-beta-carboline alkaloids which were linked with different substituted nitrogen-containing heterocycles at the positions-N9, and their in vitro biological activities were evaluated. It was found that most hybrids showed good to moderate anti-tumor activities. Especially, compound 9j had a great potency superior to 5-fluorouracil (5-FU) and comparable to adriamycin in human cancer cells, and could selectively inhibit tumor cells, but not inhibit non-tumor cell proliferation in vitro. More importantly, apoptosis assay indicated that 9j could significantly induce tumor cell apoptosis in a dose-dependent manner. Therefore, our novel findings may provide a new framework for the design of new hybrids for the intervention of human cancers.
引用
收藏
页码:343 / 349
页数:7
相关论文
共 24 条
[1]   Bioengineering Strategies for Designing Targeted Cancer Therapies [J].
Alexander-Bryant, Angela A. ;
Vanden Berg-Foels, Wendy S. ;
Wen, Xuejun .
ADVANCES IN CANCER RESEARCH, VOL 118, 2013, 118 :1-59
[2]   Ferulic Acid Inhibits 7,12-Dimethylbenz[a] anthracene-Induced Hamster Buccal Pouch Carcinogenesis [J].
Balakrishnan, Subramanian ;
Menon, Venugopal P. ;
Manoharan, Shanmugam .
JOURNAL OF MEDICINAL FOOD, 2008, 11 (04) :693-700
[3]  
Bharate SB, 2012, MINI-REV MED CHEM, V12, P650
[4]   Design, synthesis and cardioprotective effect of a new class of dual-acting agents:: Phenolic tetrahydro-β-carboline RGD peptidomimetic conjugates [J].
Bi, Wei ;
Cai, Jianhui ;
Liu, Sanguang ;
Baudy-Floc'h, Michele ;
Bi, Lanrong .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (22) :6909-6919
[5]  
Bombrun A., 2001, U.S. Patent, Patent No. [6, 306, 870B1, 6306870]
[6]   Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine [J].
Cline, SD ;
Macdonald, TL ;
Osheroff, N .
BIOCHEMISTRY, 1997, 36 (42) :13095-13101
[7]   Hybrid Compound Design To Overcome the Gatekeeper T338M Mutation in cSrc [J].
Getlik, Matthaeus ;
Gruetter, Christian ;
Simard, Jeffrey R. ;
Klueter, Sabine ;
Rabiller, Matthias ;
Rode, Haridas B. ;
Robubi, Armin ;
Rauh, Daniel .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (13) :3915-3926
[8]   Design of β-carboline derivatives as DNA-targeting antitumor agents [J].
Guan, Huaji ;
Chen, Hongsheng ;
Peng, Wenlie ;
Ma, Yan ;
Cao, Rihui ;
Liu, Xiaodong ;
Xu, Anlong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2006, 41 (10) :1167-1179
[9]   Oxidative Metabolism of the Bioactive and Naturally Occurring β-Carboline Alkaloids, Norharman and Harman, by Human Cytochrome P450 Enzymes [J].
Herraiz, Tomas ;
Guillen, Hugo ;
Aran, Vicente J. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (11) :2172-2180
[10]   Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention [J].
Huang, Wu-Yang ;
Cai, Yi-Zhong ;
Zhang, Yanbo .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (01) :1-20